GCC HIV Drugs Market Overview:
The GCC HIV drugs market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. The market is projected to register a CAGR of X% during 2023-2028, reaching US$ XX Billion by 2028. HIV drugs are medications that are used to treat the Human Immunodeficiency Virus (HIV) disease, which is transmitted from one individual to another through blood-to-blood and sexual contact. HIV attacks immune cells, known as CD-4 cells, making the body more exposed to infections and other diseases. Even though HIV cannot be effectively treated, it can be controlled through prescribed medications and help prevent the spread of the disease. In recent years, HIV drugs have gained traction on account of the rising incidences of HIV disease across the GCC region.
One of the primary factors driving the market is the rising number of individuals diagnosed with acquired immunodeficiency syndrome (AIDS) among the masses. Additionally, the increasing awareness among individuals about the treatment for AIDS is creating a positive market outlook. Other than this, several initiatives are undertaken by government and non-government organizations (NGOs) to promote awareness in the GCC region, which is influencing the market growth. Besides this, the launch of numerous generic drugs is propelling the market growth. In line with this, key players are extensively investing in research and development (R&D) activities in confluence with the rising clinical trials and product launches. Apart from these factors, constant technological advancements in drug manufacturing procedures represent another major growth-inducing factor. Furthermore, the growing trend of online pharmacies, along with the introduction of home delivery models, is creating lucrative growth opportunities for the key players operating in the industry. Moreover, the rising number of new product variants and the increasing drug approvals are accelerating the product adoption rate. Other major growth-inducing factors include constant developments in the healthcare industry, increasing number of research laboratories and diagnostic centers, rising geriatric population, significant rise in healthcare expenditure, expanding income levels of the masses, and rapid urbanization.
Beginning with a regional overview, the report explores the dynamics that have a strong influence on the GCC HIV drugs market and can also impact its future growth. Taking 2022 as the base year, the report covers historical market scenario from 2017-2022 and provides forecasts till 2028. This includes the study of value and volume trends and pricing history. Growth inducing factors, market restraints and recent developments have also been analysed in the report in order to provide a deeper knowledge about the industry. On a regional basis, the report examines the GCC HIV drugs market in Saudi Arabia, United Arab Emirates, Qatar, Kuwait, Oman and Bahrain. For each of these regions, the report studies the GCC HIV drugs market in detail for latest trends, outlook and opportunities.
The report analyses the competitive structure of the GCC HIV drugs market industry and provides the profiles of major players operating in the market. The price margins for the products along with the various success and risk factors for manufacturers have also been covered in the report. Moreover, in order to determine market attractiveness, the report analyses the GCC HIV drugs market industry along the parameters of the Porter’s Five Forces model. This model examines the degree of competition in the GCC HIV drugs market industry by analysing the threat posed by new entrants and substitutes, and the bargaining power of suppliers and buyers. SWOT analysis of the market has also been presented in the report which highlights the strengths, weaknesses, opportunities and threats pertaining to the GCC HIV drugs market industry. Furthermore, the value chain analysis of the GCC HIV drugs market industry has also been covered in the report. This comprises of all the activities in the value chain, such as the procurement of various raw materials, manufacturing, sales and distribution.
GCC HIV drugs Market Segment Insights:
The GCC HIV drugs market has been analysed as followed:
By Drug Class:
By Distribution Channel:
By Country:
Country-wise, the market has been segmented into Saudi Arabia, United Arab Emirates, Qatar, Kuwait, Oman and Bahrain. Amongst these, Saudi Arabia represents the largest market, accounting for majority of the GCC region.
Competative Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Highlights of the GCC HIV Drugs Market Report:
Report Customisation:
The GCC HIV drugs market report can be customised as per your requirements. You can get in touch with our analyst, who will make sure that the report suits your research needs.
1 Introduction
1.1 Research Objectives
1.2 Stakeholders
1.3 Scope of the Report
1.4 Assumptions and Limitations
2 Research Methodology
2.1 Data Collection
2.1.1 Primary Sources
2.1.2 Secondary Sources
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Data Validation
3 Executive Summary
4 Global HIV Drugs Market
4.1 Historical Market Trend
4.2 Market Segmentation by Region
4.3 Market Outlook
5 GCC HIV Drugs Market
5.1 Industry Overview
5.2 Key Industry Developments
5.3 Market Trends
5.3.1 Key Market Indicators
5.3.2 Historical Market Trends
5.3.3 Impact of COVID-19
5.3.4 Market Outlook
6 GCC HIV Drugs Market Segmentation by Country
6.1 Saudi Arabia
6.1.1 Historical Market Trends
6.1.2 Market Outlook
6.2 United Arab Emirates
6.2.1 Historical Market Trends
6.2.2 Market Outlook
6.3 Qatar
6.3.1 Historical Market Trends
6.3.2 Market Outlook
6.4 Kuwait
6.4.1 Historical Market Trends
6.4.2 Market Outlook
6.5 Oman
6.5.1 Historical Market Trends
6.5.2 Market Outlook
6.6 Bahrain
6.6.1 Historical Market Trends
6.6.2 Market Outlook
7 GCC HIV Drugs Market Segmentation by Drug Class
7.1 Nucleoside Reverse Transcriptase Inhibitors
7.1.1 Historical Market Trends
7.1.2 Market Outlook
7.2 Multi-Class Combination Products
7.2.1 Historical Market Trends
7.2.2 Market Outlook
7.3 Protease Inhibitors
7.3.1 Historical Market Trends
7.3.2 Market Outlook
7.4 HIV Integrase Strand Transfer Inhibitors
7.4.1 Historical Market Trends
7.4.2 Market Outlook
7.5 Non-Nucleoside Reverse Transcriptase Inhibitors
7.5.1 Historical Market Trends
7.5.2 Market Outlook
7.6 Entry Inhibitors — CCR5 Co-Receptor Antagonist
7.6.1 Historical Market Trends
7.6.2 Market Outlook
7.7 Fusion Inhibitors
7.7.1 Historical Market Trends
7.7.2 Market Outlook
8 GCC HIV Drugs Market Segmentation by Distribution Channel
8.1 Hospital Pharmacies
8.1.1 Historical Market Trends
8.1.2 Market Outlook
8.2 Retail Pharmacies
8.2.1 Historical Market Trends
8.2.2 Market Outlook
8.3 Online Pharmacies
8.3.1 Historical Market Trends
8.3.2 Market Outlook
8.4 Others
8.4.1 Historical Market Trends
8.4.2 Market Outlook
9 GCC HIV Drugs Industry: Market Dynamics
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats
10 GCC HIV Drugs Industry: Value Chain Analysis
10.1 Overview
10.2 Research and Development
10.3 Raw Material Suppliers
10.4 Inbound Logistics
10.5 Production
10.6 Marketing
10.7 Outbound Logistics
10.8 Consumers
11 GCC HIV Drugs Industry: Porter’s Five Forces Analysis
11.1 Overview
11.2 Threat of New Entrants
11.3 Threat of Substitutes
11.4 Bargaining Power of Buyers
11.5 Bargaining Power of Suppliers
11.6 Intensity of Rivalry
12 Competitive Landscape
12.1 Market Structure
12.2 Key Players
12.3 Key Success Factors
13 Key Player Profiles
List of Figures
Figure 1: Global: HIV Drugs Market: Sales Value (in Billion US$), 2017-2022
Figure 2: Global: HIV Drugs Market: Segmentation by Region (in %), 2022
Figure 3: Global: HIV Drugs Market Outlook: Sales Value (in Billion US$), 2023-2028
Figure 4: GCC: HIV Drugs Market: Sales Value (in Billion US$), 2017-2022
Figure 5: GCC: HIV Drugs Market Outlook: Sales Value (in Billion US$), 2023-2028
Figure 6: GCC: HIV Drugs Market: Segmentation by Country (in %), 2022
Figure 7: GCC: HIV Drugs Market: Segmentation by Drug Class (in %), 2022
Figure 8: GCC: HIV Drugs Market: Segmentation by Distribution Channel (in %), 2022
Figure 9: Saudi Arabia: HIV Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Saudi Arabia: HIV Drugs Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 11: United Arab Emirates: HIV Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: United Arab Emirates: HIV Drugs Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 13: Qatar: HIV Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Qatar: HIV Drugs Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 15: Kuwait: HIV Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Kuwait: HIV Drugs Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 17: Oman: HIV Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Oman: HIV Drugs Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 19: Bahrain: HIV Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Bahrain: HIV Drugs Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 21: GCC: HIV Drugs (Nucleoside Reverse Transcriptase Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: GCC: HIV Drugs (Nucleoside Reverse Transcriptase Inhibitors) Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 23: GCC: HIV Drugs (Multi-Class Combination Products) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: GCC: HIV Drugs (Multi-Class Combination Products) Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 25: GCC: HIV Drugs (Protease Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: GCC: HIV Drugs (Protease Inhibitors) Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 27: GCC: HIV Drugs (HIV Integrase Strand Transfer Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: GCC: HIV Drugs (HIV Integrase Strand Transfer Inhibitors) Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 29: GCC: HIV Drugs (Non-Nucleoside Reverse Transcriptase Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: GCC: HIV Drugs (Non-Nucleoside Reverse Transcriptase Inhibitors) Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 31: GCC: HIV Drugs (Entry Inhibitors — CCR5 Co-Receptor Antagonist) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: GCC: HIV Drugs (Entry Inhibitors — CCR5 Co-Receptor Antagonist) Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 33: GCC: HIV Drugs (Fusion Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: GCC: HIV Drugs (Fusion Inhibitors) Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 35: GCC: HIV Drugs (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: GCC: HIV Drugs (Hospital Pharmacies) Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 37: GCC: HIV Drugs (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: GCC: HIV Drugs (Retail Pharmacies) Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 39: GCC: HIV Drugs (Online Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: GCC: HIV Drugs (Online Pharmacies) Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 41: GCC: HIV Drugs (Others) Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: GCC: HIV Drugs (Others) Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 43: GCC: HIV Drugs Industry: Market Dynamics
Figure 44: GCC: HIV Drugs Industry: Value Chain Analysis
Figure 45: GCC: HIV Drugs Market: Porter’s Five Forces Analysis
List of Tables
Table 1: GCC: HIV Drugs Market: Key Industry Highlights, 2022 and 2028
Table 2: GCC: HIV Drugs Market Outlook: Segmentation by Country (in Million US$), 2023-2028
Table 3: GCC: HIV Drugs Market Outlook: Segmentation by Drug Class (in Million US$), 2023-2028
Table 4: GCC: HIV Drugs Market Outlook: Segmentation by Distribution Channel (in Million US$), 2023-2028
Table 5: GCC: HIV Drugs Market Structure
Table 6: GCC: HIV Drugs Market: Key Players
Personalize this research
Triangulate with your own data
Get data as per your format and definition
Gain a deeper dive on a specific application, geography, customer or competitor
Any level of personalization
US: +1-213-316-7435
Uk: +44-702-409-7740
sales@syndicatedanalytics.com
The GCC Weight Management Market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. The market is projected to register a CAGR of X% during 2023-2028, reaching US$ XX Billion by 2028.
Read More The GCC orthopedic braces and supports market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. Looking forward, the market is projected to grow at a CAGR of around X% during 2023-2028, reaching a value of US$ XX Billion by 2028.
Read MoreThe GCC generic drug market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. Looking forward, the market is projected to grow at a CAGR of around X% during 2023-2028, reaching a value of US$ XX Billion by 2028.
Read MoreThe GCC telemedicine market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. Looking forward, the market is projected to grow at a CAGR of around X% during 2023-2028, reaching a value of US$ XX Billion by 2028.
Read MoreThe UAE mhealth market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. Looking forward, the market is projected to grow at a CAGR of around X% during 2023-2028, reaching a value of US$ XX Billion by 2028.
Read MoreThe Saudi Arabia health insurance market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. Looking forward, the market is projected to grow at a CAGR of around X% during 2023-2028, reaching a value of US$ XX Billion by 2028.
Read More+1-213-316-7435
us.sales@syndicatedanalytics.com
+44-702-409-7740
uk.sales@syndicatedanalytics.com
© Copyright Syndicated Analytics 2023.